FDA awards 21 grants to stimulate product development for rare diseases
The U.S. Food and Drug Administration today announced that it has awarded 21 new clinical trial research grants totaling more than $23 million over the next four years to boost the development of products for patients with rare diseases.
Click on this link for more information.
